IFNG and type 1 diabetes mellitus: In patients with autoimmune diseases, such as type 1 diabetes (T1D) or MS, the frequency of IFN-γ+ Foxp3+ tTreg with lower suppressive activity is augmented in the blood compared to healthy donors.